Cargando…

Editorial: From Chronic Inflammation to Cancer: How Far Can Immunotherapy Go?

Detalles Bibliográficos
Autores principales:	Li, Xuefeng, Teng, Lesheng, Yang, Zhaogang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820386/ https://www.ncbi.nlm.nih.gov/pubmed/35140611 http://dx.doi.org/10.3389/fphar.2021.838917

Ejemplares similares

Chronic inflammation, cancer development and immunotherapy
por: Wen, Yalei, et al.
Publicado: (2022)

Anaplastic thyroid cancer: How far can we go?
por: Amaral, Mariana, et al.
Publicado: (2020)

Cell-Penetrating Peptides in Diagnosis and Treatment of Human Diseases: From Preclinical Research to Clinical Application
por: Xie, Jing, et al.
Publicado: (2020)

How far can we go in precision with ALR?
por: Blondel, A
Publicado: (1990)

Biologics: how far can they go in Crohn’s disease?
por: Dunleavy, Katie A, et al.
Publicado: (2022)

Elagolix: How far can it go in the world of gynecology?
por: Danis, Rachel B.
Publicado: (2023)

Digital drainage system: how far can we go?
por: Costa, Altair da Silva, et al.
Publicado: (2014)

TAV-in-TAV and Beyond: How Far Can We Go?
por: Taramasso, Maurizio, et al.
Publicado: (2023)

Tailoring radicality in early cervical cancer: how far can we go?
por: van der Velden, Jacobus, et al.
Publicado: (2018)

Paediatric Surgery on the African Continent: How Far Have We Come; How Far Can We Go?
por: Numanoglu, Alp
Publicado: (2023)

Editorial: Targeted Immunotherapy for Cancer
por: Williams, Williams V.
Publicado: (2022)

Shrinking Your Deictic System: How Far Can You Go?
por: Vulchanova, Mila, et al.
Publicado: (2020)

Static test flakiness prediction: How Far Can We Go?
por: Pontillo, Valeria, et al.
Publicado: (2022)

How far can omics go in unveiling the mechanisms of floral senescence?
por: Rogers, Hilary J.
Publicado: (2023)

How Far From Stability Can We Go Using Gammasphere and the FMA?
por: Lister, C. J.
Publicado: (2000)

Exosomes as smart drug delivery vehicles for cancer immunotherapy
por: Zhang, Huan, et al.
Publicado: (2023)

Working alliance with an avatar: How far can we go with internet interventions?
por: Heim, Eva, et al.
Publicado: (2018)

Editorial: Chronic Inflammation and Neurodegeneration in Retinal Disease
por: Petrillo, Francesco, et al.
Publicado: (2021)

Editorial: The Role of Natural Products in Chronic Inflammation
por: Deng, Wenjun, et al.
Publicado: (2022)

Editorial: Chronic inflammation and pharmacological interventions in cardiovascular diseases
por: Wang, Xiaoping, et al.
Publicado: (2022)

Editorial: Enteric inflammation and chronic diseases: Is there a link?
por: Marzocco, Stefania, et al.
Publicado: (2022)

Bioabsorbable Suture Anchor Migration to the Acromioclavicular Joint: How Far Can These Implants Go?
por: Medina, Giovanna, et al.
Publicado: (2014)

In Vitro Modeling of Non-Solid Tumors: How Far Can Tissue Engineering Go?
por: Clara-Trujillo, Sandra, et al.
Publicado: (2020)

Editorial: Chronic Inflammation and Neurodegeneration in Retinal Disease, Volume II
por: Bucolo, Claudio, et al.
Publicado: (2022)

Editorial: The challenges of drug repurposing in diseases related to chronic inflammation
por: Collotta, Debora, et al.
Publicado: (2023)

Editorial: Therapeutic Effects of Herbal Medicines: How Can We Best Investigate Bioactive Metabolites?
por: Ji, Shuai, et al.
Publicado: (2022)

Editorial: Multi-omics approaches for decoding heterogeneity in cancer immunotherapy
por: Jiang, Aimin, et al.
Publicado: (2023)

Simplified TAVR Procedure: How Far Is It Possible to Go?
por: Leclercq, Florence, et al.
Publicado: (2022)

Multiple renal arteries challenge in laparoscopic donor nephrectomy: how far can we go?
por: Genc, Volkan, et al.
Publicado: (2011)

Pushing the Limits of Surgical Resection in Colorectal Liver Metastasis: How Far Can We Go?
por: Calderon Novoa, Francisco, et al.
Publicado: (2023)

Editorial: Chronic inflammation and pharmacological interventions in cardiovascular diseases, volume II
por: Yan, Aiwei, et al.
Publicado: (2023)

Nanotechnology and Microtechnology in Drug Delivery Systems
por: Sun, Jingyao, et al.
Publicado: (2020)

Milestones in Heart Failure: How Far We Have Come and How Far We Have Left to Go
por: Gajjela, Harini, et al.
Publicado: (2021)

Editorial: Inflammation and aging in chronic and degenerative diseases: Current and future therapeutic strategies
por: Falzone, Luca, et al.
Publicado: (2023)

Editorial: Medicinal plants in the treatment of gastrointestinal cancers: How can OMICS and other advanced approaches help in understanding their mechanisms of action?
por: Feng, Yibin, et al.
Publicado: (2022)

Cut it and forget it: Can patient agency go too far?
por: Leunig, Alexander A.W., et al.
Publicado: (2023)

Robot-assisted urological surgery in the Middle East: Where are we and how far can we go?
por: Azhar, Raed A., et al.
Publicado: (2019)

Undergraduate medical education; how far should we go?
por: Benamer, Hani TS
Publicado: (2007)

Forensic DNA phenotyping in Europe: How far may it go?
por: Zieger, Martin
Publicado: (2022)

The cost of cancer care: how far would you go for a trial?
por: Fitzpatrick, Orla M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vi3gmfb974kss27s6n0p3806ng